Operating income increased 375.1%
Operating income changed +375.1% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +375.1% from the comparable as-filed period.
Inventory changed -12.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +551 basis points from the comparable as-filed period.
Gross margin changed +548 basis points from the comparable as-filed period.
Trade receivables changed -21.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Revenue changed -25.0% from the comparable as-filed period.
Free-cash-flow proxy changed -27.0% from the comparable as-filed period.
Operating cash flow changed -27.7% from the comparable as-filed period.
Research & development changed -37.6% from the comparable as-filed period.
Shares outstanding changed -3.4% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Inventory / revenue changed +1355 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.